Chiropractors in Lovettsville, VA Accepting Medicare

4 Chiropractors found. Showing 1 - 4

Dr. Tanya Lynn Pederson, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 12365 Elvan Rd, Lovettsville, VA 20180 Phone: 703-431-2535

Dr. Nicholas Robert Summerfelt, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 20 Town Sq Unit 130, Lovettsville, VA 20180 Phone: 540-668-5837    Fax: 540-668-5838

Palmercare Chiropractic Lovettsville Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 20 Town Sq Unit 130, Lovettsville, VA 20180 Phone: 571-264-0643

Rebecca Flannagan, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 20 Town Sq Unit 130, Lovettsville, VA 20180 Phone: 540-668-5837    Fax: 703-421-2822

News Archive

Bausch + Lomb ReNu MultiPlus multi-purpose solution named "Best Eye Care Product of the Year - Asia"

Bausch + Lomb ReNu MultiPlus(R) multi-purpose solution has been named "Best Eye Care Product of the Year - Asia" for its revolutionary bottle design at this year's A.S. Watson Global Suppliers Awards. Held in Hong Kong on 4 March 2010, the awards recognize international brands for outstanding performance in bringing innovation, differentiation and excitement to the consumer experience.

New therapeutic technique to repair and rebuild muscle for degenerative muscle disorders

A study published today in BioMed Central's open access journal Skeletal Muscle reports of a new therapeutic technique to repair and rebuild muscle for sufferers of degenerative muscle disorders. The therapy brings together two existing techniques for muscle repair - cell transplantation and tissue engineering - specifically, mesoangioblast stem cells delivered via a hydrogel cell-carrier matrix.

Updated results from phase III EXTEND clinical trial of pixantrone released

Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.

Researchers discover a startling feature of early brain development

Researchers at the Salk Institute have discovered a startling feature of early brain development that helps to explain how complex neuron wiring patterns are programmed using just a handful of critical genes. The findings, published February 3 in Cell, may help scientists develop new therapies for neurological disorders, such as amyotrophic lateral sclerosis (ALS), and provide insight into certain cancers.

Read more Medical News

› Verified 7 days ago